Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Beth

Synairgen’s SNG001 will prevent cell damage in fight against coronavirus pandemic

Synairgen has received approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 (inhaled interferon-beta-1a) in coronavirus (COVID-19) patients. SNG001 will prevent cell damage in a similar fashion to that of multiple sclerosis (MS) patients, says GlobalData, a leading data and analytics company. Synairgen […]
Read more

UK household insurance gross written premiums fall by 4.9% in 2018 to £6.2bn

Generation rent is an impeding factor on the household insurance market, with start-ups and some incumbents now offering flexible renters’ cover. Under the backdrop of a decline in UK household insurance gross written premiums (GWP), which fell by 4.9% to £6.2bn in 2018, this transition within the market creates a harder environment for insurers, who will likely see combined policies decline and a rise in cheaper landlords’ and renters’ policies, says GlobalData, a leading data and […]
Read more
,

Uncertainty looms over oil and gas M&A deals landscape amidst coronavirus outbreak and drop in oil prices

The recent coronavirus (COVID-19) outbreak is adding further woes for the oil and gas industry, which is already plagued by oversupply and declining prices. This is expected to affect the completion of announced and planned mergers and acquisitions (M&A) deals, according to GlobalData, a leading data and analytics company. GlobalData’s deals database identifies that a […]
Read more

GlobalData ensuring business continuity and client support in challenging times

Since the outbreak of COVID-19 was confirmed, GlobalData has been closely monitoring and ensuring the timely implementation of the recommendations and advice of the World Health Organization (WHO) to its business operations around the world. This extends to heeding the advice issued by local government and relevant health authorities where we have business operations. Whilst […]
Read more

Thermo Fisher to be key player in COVID-19 diagnostic tests following acquisition of Qiagen

Thermo Fisher Scientific is expected to produce millions of coronavirus (COVID-19) diagnostic tests following the acquisition of Qiagen for an approximate transaction value of US$11.5bn per share, says GlobalData, a leading data and analytics company. Qiagen, a provider of molecular diagnostics and sample preparation technologies, offers a long list of nucleic acid amplification tests (NAATs) […]
Read more

ACC’s virtual scientific session may limit impact of COVID-19 pandemic on cardiovascular research and market

Following the cancelation of the 2020 Scientific Session due to the coronavirus (COVID-19), the American College of Cardiology (ACC) has created a virtual three-day scientific session in order to minimize any impact to the advancement of cardiology research. However, this may limit the impact of the COVD-19 pandemic on cardiovascular research, says GlobalData, a leading […]
Read more

Superdry’s comeback firmly in doubt as coronavirus hits its recovery

Following today’s news (Wednesday 18 March) that Superdry has issued a profit warning; Kate Ormrod, Lead Retail Analyst at GlobalData, a leading data and analytics company, offers her view: “Given Superdry’s profit warning in early January following poor festive trading, today’s announcement that it will miss its revised FY2019/20 profit target was inevitable given the […]
Read more

COVID-19 cases in US could total more than 228,000 by end of March

There has been an exponential increase of coronavirus (COVID-19) cases in the US since the beginning of March, from less than 70 to more than 4,000. In just two more weeks, there could be over 228,000 confirmed cases, says GlobalData, a leading data and analytics company. Kasey Fu, Director of Epidemiology at GlobalData, comments: “Depending […]
Read more

Tessa Therapeutics TT11 will replace stem cell transplants as standard of care in Hodgkin’s lymphoma

Tessa Therapeutics’ TT11 has become the first CAR-T therapy to receive the Food and Drug Administration (FDA) regenerative medicine advanced therapy (RMAT) designation and is set to become the leading cell-based therapy in Hodgkin’s lymphoma (HL), displacing the outdated stem cell transplants as the standard of care by 2024, says GlobalData, a leading data and analytics company. Miguel Ferreira, MSc, Oncology and Hematology Analyst at GlobalData, comments: “TT11, being the first CAR-T therapy to emerge from […]
Read more

Global capsule endoscopes market set to reach $401.4m by 2028

The global capsule endoscopes market is expected to reach $401.4m by 2028, growing at a compound annual growth rate (CAGR) of 4.2%, according to GlobalData, a leading data and analytics company. The company’s recent report, ‘Capsule Endoscopes – Medical Devices Pipeline Assessment, 2020’, reveals that the Asia Pacific region will be one of the fastest growing […]
Read more

M&A activity across media industry witnesses consistent volume growth but showcases decline in value

A total of 839 mergers and acquisitions (M&A) deals were announced in the global media (including advertising), communication and collaboration services sector during 2019, according to GlobalData, a leading data and analytics company. An analysis of GlobalData’s deals database reveals that the number of M&A deals in this sector has been consistently increasing with the […]
Read more

As Boeing’s problems mount Airbus sales stall

As setbacks for Boeing’s 737 MAX accumulate, uncertainty over its path to recertification continues to impact companies within Boeing’s US supply chain, says GlobalData, a leading data and analytics company. While some companies attempt to solicit business elsewhere, others cut jobs in order to deal with reduced demand. For example, General Electric has moved towards […]
Read more

Angina landscape shifting towards increased recognition of microvascular angina in clinical practice

Microvascular angina (MVA) is being increasingly recognized in clinical practice, says GlobalData, a leading data and analytics company. According to key opinion leaders (KOLs) interviewed by GlobalData, patients with exertional angina and symptoms strongly suggestive of coronary artery disease (CAD) were previously often disregarded since the diagnosis of chronic stable angina was highly related to […]
Read more
1 … 66 67 68 69 70 … 93